Harvard Business Review on the disbanding of Haven, the venture to disrupt U.S. health care formed by Amazon, Berkshire Hathaway, and JPMorgan Chase:[1]
>Perverse incentives. We still live in a world where the larger portion of hospitals’ beds that are utilized, the more they get paid. Consequently, the U.S. health system is focused on treating sickness rather than preventing illness in the first place.
It seems like your root cause analysis is broadly known. Do you expect the market to shift quickly once your approach gains traction?